May 13, 2015

Aethlon Medical Announces Health Canada Approval of Ebola Treatment Protocol

May 12, 2015

Aethlon Medical Announces Institutional Review Board Approval of Multi-Indication Cancer Study

May 4, 2015

Aethlon Medical Announces Withdrawal of S-1 Registration Statement

Apr 16, 2015

Aethlon Medical Discloses Presentation of Preliminary CTE Related Study Results

Apr 15, 2015

Aethlon Medical Announces Cancer Clinical Trial Agreement

Apr 14, 2015

Aethlon Medical Announces Effectiveness of Reverse Stock Split

Apr 9, 2015

Aethlon Medical Announces Ebola Humanitarian Use Device Submission to the FDA

Apr 8, 2015

Aethlon Medical Announces Reverse Stock Split and Nasdaq Listing Submission

Apr 2, 2015

Aethlon Medical Discloses Head and Neck Cancer Collaboration

Mar 6, 2015

Update - Changed Time for Aethlon Medical Presentation at the 27th Annual ROTH Conference